Display options
Share it on

J Clin Med. 2021 Apr 13;10(8). doi: 10.3390/jcm10081653.

Predictive Value of Pro-BNP for Heart Failure Readmission after an Acute Coronary Syndrome.

Journal of clinical medicine

Alberto Cordero, Elías Martínez Rey-Rañal, María J Moreno, David Escribano, José Moreno-Arribas, Maria A Quintanilla, Pilar Zuazola, Julio Núñez, Vicente Bertomeu-González

Affiliations

  1. Cardiology Department, Hospital Universitario de San Juan, 03550 Alicante, Spain.
  2. Unidad de Investigación en Cardiología, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020 Valencia, Spain.
  3. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV CB16/11/00226-CB16/11/00420), 28028 Madrid, Spain.
  4. Cardiology Department, Hospital Clínico Universitario, 46010 Valencia, Spain.
  5. Instituto de Investigación Sanitaria (INCLIVA), Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.

PMID: 33924437 PMCID: PMC8069470 DOI: 10.3390/jcm10081653

Abstract

BACKGROUND: N-terminal pro-brain natural peptide (NT-pro-BNP) is a well-established biomarker of tissue congestion and has prognostic value in patients with heart failure (HF). Nonetheless, there is scarce evidence on its predictive capacity for HF re-admission after an acute coronary syndrome (ACS). We performed a prospective, single-center study in all patients discharged after an ACS. HF re-admission was analyzed by competing risk regression, taking all-cause mortality as a competing event. Results are presented as sub-hazard ratios (sHR). Recurrent hospitalizations were tested by negative binomial regression, and results are presented as incidence risk ratio (IRR).

RESULTS: Of the 2133 included patients, 528 (24.8%) had HF during the ACS hospitalization, and their pro-BNP levels were higher (3220 pg/mL vs. 684.2 pg/mL;

CONCLUSIONS: In-hospital determination of pro-BNP is an independent predictor of HF readmission after an ACS.

Keywords: acute coronary syndrome; heart failure; pro-BNP

References

  1. J Am Heart Assoc. 2018 Oct 2;7(19):e009162 - PubMed
  2. Eur Heart J. 2016 Jul 14;37(27):2129-2200 - PubMed
  3. Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):820-828 - PubMed
  4. Eur J Heart Fail. 2014 Jan;16(1):33-40 - PubMed
  5. J Am Coll Cardiol. 2018 Jan 30;71(4):386-398 - PubMed
  6. Lancet. 2021 Jan 30;397(10272):370-371 - PubMed
  7. Int J Cardiol. 2020 May 1;306:116-122 - PubMed
  8. Int J Cardiol. 2017 Dec 15;249:301-307 - PubMed
  9. J Am Heart Assoc. 2016 May 20;5(5): - PubMed
  10. J Card Fail. 2017 Aug;23(8):628-651 - PubMed
  11. JACC Cardiovasc Imaging. 2019 Dec;12(12):2445-2456 - PubMed
  12. JAMA Cardiol. 2018 Dec 1;3(12):1160-1166 - PubMed
  13. N Engl J Med. 2003 Apr 3;348(14):1309-21 - PubMed
  14. JAMA Cardiol. 2020 Apr 1;5(4):401-410 - PubMed
  15. PLoS Med. 2007 Oct 16;4(10):e296 - PubMed
  16. Am J Cardiol. 2017 Jun 1;119(11):1729-1739 - PubMed
  17. Am J Cardiol. 2020 Apr 15;125(8):1194-1201 - PubMed
  18. Am J Cardiol. 2020 Dec 1;136:15-23 - PubMed
  19. Cardiovasc Res. 2020 May 1;116(6):1101-1112 - PubMed
  20. Am J Cardiol. 2018 Jul 1;122(1):1-5 - PubMed
  21. Arch Intern Med. 2003 Oct 27;163(19):2345-53 - PubMed
  22. JACC Cardiovasc Imaging. 2021 Feb;14(2):393-407 - PubMed
  23. Eur Heart J Acute Cardiovasc Care. 2019 Oct;8(7):652-659 - PubMed
  24. J Am Coll Cardiol. 2019 Apr 23;73(15):1931-1944 - PubMed
  25. Circ Heart Fail. 2020 Feb;13(2):e006472 - PubMed
  26. Am Heart J. 2019 Sep;215:83-90 - PubMed
  27. JAMA Cardiol. 2021 Feb 10;: - PubMed
  28. Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1075-84 - PubMed
  29. Ann Intern Med. 2009 May 5;150(9):604-12 - PubMed
  30. J Am Coll Cardiol. 2018 May 15;71(19):2079-2088 - PubMed
  31. J Card Fail. 2020 Oct;26(10):876-884 - PubMed
  32. Am J Cardiol. 2016 Apr 1;117(7):1088-94 - PubMed
  33. J Am Coll Cardiol. 2004 Feb 18;43(4):576-82 - PubMed
  34. JACC Heart Fail. 2016 Nov;4(11):833-843 - PubMed
  35. N Engl J Med. 2001 Oct 4;345(14):1014-21 - PubMed

Publication Types